Completed PHASE1 INTERVENTIONAL 4-arm NCT04626414

Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy Volunteers

A Randomized, Open-Label, Single Dose, Four-Way Crossover, Phase I Study to Compare the Pharmacokinetics of Ferric Maltol Capsules and Oral Suspension Under Fasted and Fed Conditions in Adult Healthy Volunteers

Sponsor: Shield Therapeutics

Conditions Anemia, Iron Deficiency

Interventions Ferric maltol capsule Ferric maltol suspension

Updated 6 times since 2020 Last updated: Aug 6, 2025 Started: Sep 28, 2020 Primary completion: Nov 13, 2020 Completion: Nov 13, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Anemia, Iron Deficiency and is currently completed. Shield Therapeutics leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1

Status: Unknown → Completed
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Dec 2022 — Jul 2024 [monthly]

Unknown Status PHASE1

Status: Recruiting → Unknown Status
Jan 2021 — Dec 2022 [monthly]

Recruiting PHASE1

▶ Show 1 earlier version

Dec 2020 — Jan 2021 [monthly]

Recruiting PHASE1

First recorded

Sep 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shield Therapeutics

Data source: Shield Therapeutics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cincinnati, United States